Johnson Financial Group LLC (Colorado)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,291
Closed -$371K 74
2021
Q4
$371K Sell
6,291
-1,935
-24% -$95.9K 0.06% 46
2021
Q3
$353K Sell
8,226
-4,630
-36% -$205K 0.07% 52
2021
Q2
$503K Buy
12,856
+2,656
+26% +$103K 0.1% 47
2021
Q1
$370K Buy
+10,200
New +$362K 0.09% 40
2017
Q1
Sell
-8,957
Closed -$276K 90
2016
Q4
$276K Buy
+8,957
New +$273K 0.22% 70

Other funds holding PFE

Johnson Financial Group LLC (Colorado)'s PFE Position: Q1 2022 in Review

Johnson Financial Group LLC (Colorado) sold out of Pfizer (PFE) in Q1 2022, closing a stake of 6,291 shares — an estimated $371K sold.

Johnson Financial Group LLC (Colorado) first reported a position in PFE in Q4 2016 and held it in 5 quarters. The position peaked at $503K in Q2 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Johnson Financial Group LLC (Colorado) reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Johnson Financial Group LLC (Colorado) sold 6,291 Pfizer shares in Q1 2022, an estimated $371K.
  • Johnson Financial Group LLC (Colorado) first reported a position in Pfizer in Q4 2016 and held it in 5 quarters.
  • Johnson Financial Group LLC (Colorado)'s Pfizer position peaked at $503K in Q2 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Johnson Financial Group LLC (Colorado)'s 13F filing for Q1 2022, filed 6 May 2022.